Allergan Layoffs

How many more WARN notices will Allergan file before the entire Irvine campus becomes empty? Saunders doesn't care either. He only cares about boosting margins and efficiencies. Haha. New Jersey is a mess, Irvine is a mess, R&D jobs for employees not in high prioritized products are gone. How many sales jobs will be affected? Saunders pretends he cares about employees but we know it's all a smoke screen. The stock price is the most important thing to him and the board.

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

AbbVie HR and integration team running on overtime mode trying to sign all the pink slips. Layoffs coming soon so be prepared!!

Restructuring in the process of being implemented via directive from AbbVie.

post

Worst company I ever worked for. I was a contractor in Madison, NJ, When they told me they were cutting my job at year's end I wanted to do a back flip ! Very abusive environment. So happy to be out of that dump!

AbbVie HR and integration team running on overtime mode trying to sign all the pink slips. Layoffs coming soon so be prepared!!

post

Worst company I ever worked for. I was a contractor in Madison, NJ, When they told me they were cutting my job at year's end I wanted to do a back flip ! Very abusive environment. So happy to be out of that dump!

post

Brent Saunders had been at the helm of Allergan for about three years now. In that time the stock has gone from about $320 to less than $140. In between there have been major screw ups, like the failed Pfizer deal and the asinine sale of the Restasis IP to an Indian tribe. The man had $40 billion dropped on him by the dopes at Teva, mostly in cash, and he even screwed that up.

What will it take for this sub-moron to finally get the unceremonious boot to the curb he deserves?

Let the pain begin.

Evolus was just approved in the U.S.

post

So while Saunders plays around on Twitter all day, we get to deal with the reality of working at Allgergan...or being laid off like I was.

Brent Saunders had been at the helm of Allergan for about three years now. In that time the stock has gone from about $320 to less than $140. In between there have been major screw ups, like the failed Pfizer deal and the asinine sale of the Restasis IP to an Indian tribe. The man had $40 billion dropped on him by the dopes at Teva, mostly in cash, and he even screwed that up.

What will it take for this sub-moron to finally get the unceremonious boot to the curb he deserves?

post

Had to repost from cafepharma. Everyone needs to read this:

What is sad is that Allergan has literally went from a great company to crap because of greed. This starts with Pyott and his desire to ride off into the sunset with $536 million from selling to Actacrap! He threw in the towel. The poison that flowed in with Saunders and company have destroyed the reputation of AGN, not to mention the poor leadership and lack of "know how" to successfully run a company has left the new "growth pharma" entity valued at less today than when the deal closed in March of 2015. Market cap has gone from over $100 billion to $55.807 as of Friday December 9th. Debt is around $30 billion. No surprise with all the bad press, Restasis uncertainty, Botox competitors coming out of the woodwork that AGN has lost a lot of value. Now the issue becomes how well will the M&A pay off that Saunders has spent oodles of money on? Did Nicholson and company do their homework on these companies and phase 2 drugs that they plunked all the money on? Apparently not! NASH looks like a bust! All it will take is a failure in a phase 3 large clinical study to wipe out more market cap as the stock tumbles. Who would buy AGN then? Just for Botox? Botox makes $4 billion/year! I lost my job when these companies merged. I feel for those still employed and dealing with uncertainty about their jobs. AGN is a **** show run by inexperienced circus clowns.

So while Saunders plays around on Twitter all day, we get to deal with the reality of working at Allgergan...or being laid off like I was.

Show Language

post

Had to repost from cafepharma. Everyone needs to read this:

What is sad is that Allergan has literally went from a great company to crap because of greed. This starts with Pyott and his desire to ride off into the sunset with $536 million from selling to Actacrap! He threw in the towel. The poison that flowed in with Saunders and company have destroyed the reputation of AGN, not to mention the poor leadership and lack of "know how" to successfully run a company has left the new "growth pharma" entity valued at less today than when the deal closed in March of 2015. Market cap has gone from over $100 billion to $55.807 as of Friday December 9th. Debt is around $30 billion. No surprise with all the bad press, Restasis uncertainty, Botox competitors coming out of the woodwork that AGN has lost a lot of value. Now the issue becomes how well will the M&A pay off that Saunders has spent oodles of money on? Did Nicholson and company do their homework on these companies and phase 2 drugs that they plunked all the money on? Apparently not! NASH looks like a bust! All it will take is a failure in a phase 3 large clinical study to wipe out more market cap as the stock tumbles. Who would buy AGN then? Just for Botox? Botox makes $4 billion/year! I lost my job when these companies merged. I feel for those still employed and dealing with uncertainty about their jobs. AGN is a **** show run by inexperienced circus clowns.

Show Language

post

20% of Botox sales come from the migraine indication and with Allergan bringing CGRP class and ubrogepant to market, those reps are going to be without jobs too.

Mylan is teaming up with Revance on a biosimilar version of Botox. No more cash cow means pressure. Pressure means cost cutting. Cost cutting means layoffs.

post

Botox doesn't need reps. All you have to do is follow one of their reps around all day and you'll be left wondering what they even do for 5 days a week.

20% of Botox sales come from the migraine indication and with Allergan bringing CGRP class and ubrogepant to market, those reps are going to be without jobs too.

post

Don't forget Botox reps.

Botox doesn't need reps. All you have to do is follow one of their reps around all day and you'll be left wondering what they even do for 5 days a week.

post

The only certainty is the CoolSculpting scam / ZELTIQ people are safe.

Don't forget Botox reps.

post

Restasis brought in $1.4 billion in sales last year with 80% margins. Do the math on how many people will eventually lose their jobs.

Growth is dead at Allergan and Sauders came out and said he doesn't know any other way to fix the Restasis competition than to lay employees off.

post

I thought it was a very stupid, last ditch effort using St. Regis Mohawks as a ethnic sheltered and viewed group to avoid the inevitable. This company isn't a Casino. Desprperate move that backfired. Guarantee he's fired by BOD within a year

Restasis brought in $1.4 billion in sales last year with 80% margins. Do the math on how many people will eventually lose their jobs.

post

Saunders should have known Restasis was going to hurt the company like it has and done more getting ahead of generics. His last minute antics in court are a worthless attempt to save the company from these pending layoffs and hopefully his salary continues to go down. The FDA has been screwed so many times by Allergan they are loving every denial they hand over.

I thought it was a very stupid, last ditch effort using St. Regis Mohawks as a ethnic sheltered and viewed group to avoid the inevitable. This company isn't a Casino. Desprperate move that backfired. Guarantee he's fired by BOD within a year

post

This is just a start. I predict at least 1 more group of cuts by the end of 2018, maybe two. Isn't this predictable though? Exec compensation continues to go up while the rest of the company gets cut to the bone, equaling the destruction of a once great company.

Your CEO took an 88% pay cut compared to 2014 salary !!!

post

Loading...


Load More

Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.